Skip to main content
Anand Patel, MD, Oncology, Brookfield, WI

AnandDhimantPatelMD

Oncology Brookfield, WI

Gastrointestinal Cancer, Genitourinary Oncology, Hematologic Oncology

M.D. | Account of Dr. Patel and his office staff

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile

Already have an account?

  • Office

    19333 W North Ave
    Brookfield, WI 53045
    Phone+1 262-780-4111

Education & Training

  • Main Line Health System/Lankenau Medical Center
    Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 2012 - 2015
  • Howard University College of Medicine
    Howard University College of MedicineClass of 2012

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2018 - 2025
  • PA State Medical License
    PA State Medical License 2012 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Dramatic Response to Olaparib in a Patient With Metastatic Castration- Resistant Prostate Cancer  
    Anand D. Patel, MD; Jessica Katz, MD, PhD, FACP; Terri W. McHugh, DO; Rachael T. Brandt, PhD, MS ; Cristina Nixon, MS; Paul B. Gilman, MD; and John Sobuto, DO, The Journal of Targeted Therapies in Cancer, 5/2/2018
  • Radiation therapy in the last month of life  
    Anand Patel, Jacquelyn Dunmore-Griffith, Stephen Lutz, Peter A.S. Johnstone, Reports of Practical Oncology and Radiotherapy, 10/16/2013

Press Mentions

  • Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention
    Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence PreventionMay 12th, 2022
  • Research Reveals a Therapeutic Opportunity to Prevent Rhabdomyosarcoma Recurrence
    Research Reveals a Therapeutic Opportunity to Prevent Rhabdomyosarcoma RecurrenceApril 27th, 2022